Pancreatic cancer and glucose metabolism

Turkish Journal of Gastroenterology

Volumn 20, Issue 4, 2009, Pages 257-260

  Saruç, Murat ^a   Karaarslan, Mehmet ^a   Rasa, Kemal ^a   Saygili, Özlem ^a   Ince, Ümit ^a   Baysal, Çaǧlar ^a   Pour, Parviz M ^b   Çakmakçi, Metin ^a   Tözün, Nurdan ^a  

^a ACIBADEM UNIVERSITY   (Turkey)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Diabetes; Glucose metabolism; Islet cells; Pancreatic cancer

Indexed keywords

INSULIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE METABOLISM; HOSPITAL ADMISSION; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POSTOPERATIVE PERIOD; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 74949089881     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2009.0022     Document Type: Article

References (25)

1. Ahmedin J, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002; 52: 23-42.
2. Cooperman AM. Pancreatic cancer: the bigger picture. Surg Clin North Am 2001; 81: 557-74.
3. Saruc M, Pour PM. Diabetes and its relationship to pancreatic carcinoma. Pancreas 2003; 26(4): 381-7.
4. Permert J, Ihse I, Jorfeldt L, et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 1993; 159: 1001-7.
5. Ishikawa ONS, Ohigashi H, Imaoka S. Increased secretion of proinsulin in patients with pancreatic cancer. Int J Pancreatol 1994; 16: 86.
6. Wang F, Herrington M, Larsson J, Permert J. The relationship between diabetes and pancreatic cancer. Mol Cancer 2003; 2: 4.
7. Kesler II. Cancer and diabetes mellitus: a review of the literature. J Chronic Dis 1971; 23: 579-600.
8. Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factor for pancreatic cancer. Br J Cancer 1999; 80: 1830-7.
9. Del Favero GBD, Fogar P, Panozzo MP, et al. Alterations of serum hormones in pancreatic cancer patients. Int J Pancreatol 1994; 16: 86.
10. Ariyama J. Abnormal glucose tolerance in patients with early pancreatic carcinoma. Int J Panc 1994; 16: 91.
11. Permert J, Ihse I, Jorfelt L, et al. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 1993; 80: 1047-50.
12. Permert J, Adrian TE, Jacobsson P, et al. Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor associated factor? Am J Surg 1993; 165: 61-6.
13. Laine VJ, Ekfors TO, Gullichsen R, et al. Immunohistochemical characterization of an amphicrine mucinous islet cell carcinoma of the pancreas. Case report. APHIS 1992; 100: 335-40.
14. Fogar P, Pasquali C, Basso D, et al. Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res 1994; 14: 2827-30.
15. Permert J, Larsson J, Westermark GT, et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med 1994; 330: 313-8.
16. Permert J, Larsson J, Fruin AB, et al. Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas 1997; 15: 60-8.
17. Li J, Adrian TE. A factor from pancreatic and colonic cancer cells stimulates glucose uptake and lactate production in myeloblasts. Biochem Biophys Res Commun 1999; 260: 626-33.
18. Basso D, Valerio A, Seraglia R, et al. Putative pancreatic cancer associated diabetogenic factor: 2030 MW peptide. Pancreas 2002; 24: 8-14.
19. Schmied BM, Ulrich A, Matsuzaki H, et al. In vitro pancreatic carcinogenesis. Ann Oncol 1999; 10(Suppl 4): 41-5.
20. Schmied B, Liu G, Moyer MP, et al. Induction of adenocarcinoma from hamster pancreatic islet cells treated with N-nitrosobis(2-oxopropyl)amine in vitro. Carcinogenesis 1999; 20: 317-24.
21. Schmied BM, Ulrich AB, Matsuzaki H, et al. Biologic instability of pancreatic cancer xenografts in the nude mouse. Carcinogenesis 2000; 21: 1121-7.
22. Tezel E, Kawase Y, Takeda S, et al. Expression of neural cell adhesion molecule in pancreatic cancer. Pancreas 2001; 22: 122-5.
23. Kamisawa T, Fukayama M, Tabata I, et al. Neuroendocrine differentiation in pancreatic duct carcinoma special emphasis on duct-endocrine cell carcinoma of the pancreas. Pathol Res Pract 1996; 192: 901-8.
24. Pour PM, Permert J, Mogaki M, et al. Endocrine aspect of exocrine cancer of the pancreas: the patterns and suggested biologic significance. Am J Clin Pathol 1993; 100: 223-30.
25. Amikura K, Kobari M, Matsuna S. The time of occurrence of liver metastasis in carcinoma of the pancreas. Int J Pancreatol 1995; 17: 139-46.